Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

LARC prolongs interpregnancy intervals but doesn’t cut preterm birth risk

Key clinical point: LARC use between pregnancies reduces short interpregnancy intervals, but not preterm birth risk.

Major finding: LARC exposure was associated with significantly reduced likelihood of short interpregnancy intervals (P less than .0001).

Study details: A retrospective cohort study of records for more than 35,000 women.

Disclosures: Dr. Simonsen and Dr. Espey reported having no relevant disclosures.

Citation:

REPORTING FROM ACOG 2019